Product Image

VOGLIBOSE (0.3MG)+GLIMEPIRIDE (3MG) + METFORMIN (500MG)

RS 164 RS 41

(0 customer review)



In stock

Metformin 500mg (SR) + Voglibose 0.3mg + Glimepiride 2 mg is a combination medication used to manage type 2 diabetes mellitus. Let's understand how each component works and how they complement each other:Metformin (500mg SR):Metformin is an oral antidiabetic medication that belongs to the class of biguanides. It works primarily by reducing the amount of glucose produced by the liver and enhancing the sensitivity of muscle cells to insulin. This leads to improved insulin utilization by the body and decreases the amount of sugar absorbed from the intestines. Metformin does not stimulate insulin secretion from the pancreas, making it different from other diabetes medications that may cause hypoglycemia (low blood sugar) as a side effect.The "SR" in the formulation stands for "sustained-release," meaning the medication is released slowly over time, providing a prolonged effect and often resulting in fewer gastrointestinal side effects.,,Voglibose (0.3mg):Voglibose is an alpha-glucosidase inhibitor. It works by blocking certain enzymes in the intestine that break down carbohydrates into simple sugars, such as glucose. By inhibiting these enzymes, voglibose slows down the absorption of glucose from the digestive tract into the bloodstream. As a result, post-meal blood sugar spikes are reduced, leading to better glucose control after meals.,,Glimepiride (2mg): Glimepiride belongs to the sulfonylurea class of medications. It works by stimulating the beta cells in the pancreas to release more insulin. This increased insulin secretion helps the body utilize glucose more effectively and lowers blood sugar levels. Glimepiride is particularly useful when the body still produces some insulin but needs help in making it more effective.Combining these three medications allows for a more comprehensive approach to managing type 2 diabetes. Metformin addresses insulin resistance and reduces glucose production in the liver. Voglibose helps control post-meal glucose spikes, while glimepiride stimulates insulin release when needed.It's important to note that the dosage and specific combination of medications can vary based on individual patient needs and medical history. The effectiveness and safety of this combination should be determined by a qualified healthcare professional who can tailor the treatment plan to the patient's unique condition. If you have any questions or concerns about your diabetes medication, it's best to consult your doctor for personalized.

Reviews (0)